Workflow
Vopimetostat (TNG462)
icon
Search documents
Tango Therapeutics (NasdaqGM:TNGX) Earnings Call Presentation
2025-10-23 12:30
Vopimetostat clinical update 23 October 2025 Certain statements in this presentation may be considered forward-looking statements. Forward-looking statements generally relate to future events, Tango's future financial and operating performance, goals, expectations, beliefs, development plans, as well as development and clinical trial objectives for Tango's product pipeline (as individual therapies and combination therapies with other party's drugs). In some cases, you can identify forward-looking statements ...